SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending as its board rejected a significantly undervalued buyout offer from its CEO, fueling speculation of a bidding war among multiple strategic parties. The community is actively debating potential higher valuations and the crucial role of Israeli government approval, given national security interests and ZIM's strong operational performance in a volatile shipping market.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow With Knife ($CAW) is trending as its community champions an organic, transparent, multi-chain project leveraging LayerZero tech across Solana, Cronos, BSC, and ETH, touting a deflationary burn mechanism and perceived utility. Enthusiasts are actively discussing its potential to lead the crypto market, contrasting with some voices calling it a pump and dump.

Moo Deng

MOODENG CRYPTO is trending due to recent significant price spikes and sustained high trading volume, with the community anticipating further parabolic gains driven by its low market cap, broad exchange availability, and speculation surrounding a potential Binance spot listing.

English version Introducing SWFTCoin (SWFTC) $SWFTC: Powering SWFT Blockchain and AI Services (SWFTGPT)  SwftCoin ($SWFTC) is the native utility token driving SWFT Blockchain's AI-powered ecosystem, SWFTGPT, and the first ever AI token featured on Coinbase. SWFTGPT is also the first domain-specific LLM for crypto.  SwftCoin key features include: 50% Reduced Transaction Fees: Lower costs on all transactions. AI Service Payments: Use $SWFTC to access SWFTGPT. Tools include expert market analysis,  predictions, and intelligent trading solutions.  Membership Benefits: Unlock premium features and AI agent services within SWFTGPT. AI-Powered Swaps: Enable precise, fast cross-chain transactions and analytics. SWFT Blockchain combines AI innovation with blockchain infrastructure, simplifying crypto trading while enhancing functionality through $SWFTC.   Chinese version $SWFTC：驱动 SWFT Blockchain 和 AI 服务（SWFTGPT） SwftCoin ($SWFTC) 是 SWFT Blockchain 的原生实用代币，为其 AI 驱动的生态系统 SWFTGPT 提供支持，同时也是 Coinbase 上首个 AI 代币。SWFTGPT 也是首个专注于加密领域的特定领域大型语言模型 (LLM)。 SwftCoin 的主要功能包括： 1、50% 交易费减免：降低所有交易成本。 2、AI 服务支付：使用 $SWFTC 访问 SWFTGPT 工具，包括专家市场分析、预测以及智能交易解决方案。 3、会员权益：解锁 SWFTGPT 的高级功能和 AI 代理服务。 4、AI 驱动的闪兑：实现精准快速的跨链交易和数据分析。 SWFT Blockchain 将 AI 创新与区块链基础设施结合，通过 $SWFTC 简化加密交易，并提升其功能性。

SwftCoin

SwftCoin (SWFTC) is trending as the community anticipates a significant price surge, drawing comparisons to its past explosive rallies and citing its current "undervalued" status with fully diluted tokenomics. Discussion centers on its core utility as an AI-integrated cross-chain exchange and interoperability solution, positioning it for potential future growth despite some concerns about developer engagement and market volume.

Direxion Shares ETF Trust - Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

GUSH is trending amidst heated community speculation driven by escalating Middle East tensions, particularly the Israel-Iran conflict and fears of disrupted oil supply routes, which many believe will spark a significant rally in energy exploration and production stocks, though others caution on volatility and potential market manipulation.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending ahead of its pivotal SOL-1 Phase 3 superiority trial data for wet AMD, with the accelerated announcement creating intense community speculation about a positive outcome. Investors are anticipating a significant valuation surge or potential acquisition if the results confirm AXPAXLI's efficacy, leading to discussions about a substantial short squeeze.

Pathward Financial, Inc. is a financial holding company, which provides savings and loan services. The firm operates through the following business segments: Consumer, Commercial, and Corporate Services/Other. The Consumer segment collaborates with partners to navigate payment and lending needs. The Commercial segment refers to the commercial finance business line, which helps businesses access funds they need to launch, operate, and grow. The Corporate Services/Other segment consists of certain shared services, treasury, retained community bank portfolio, and student loan lending. The company was founded on June 14, 1993 and is headquartered in Sioux Falls, SD.

Pathward Financial Inc

Meta Financial Group Inc.

Pathward Financial Inc. (CASH), a payment processing and bank holding company, is trending as strong earnings, including record net income and an increased dividend, attract positive analyst revisions and community interest. Discussions center on its strategic growth in financial inclusion and its position to benefit from current interest rates, even while navigating typical cyclical fee pressures.

United States Commodity Funds LLC - United States Gasoline Fund LP

United States Gasoline Fund LP

The United States Gasoline Fund (UGA) is trending amidst heightened geopolitical tensions and evolving OPEC+ supply strategies, leading to community concerns about rising gasoline prices potentially reigniting inflation and impacting consumer spending.

ONEOK, Inc. engages in gathering, processing, fractionating, transporting, storing and marketing of natural gas. It operates through the following segments: Natural Gas Gathering and Processing, Natural Gas Liquids and Natural Gas Pipelines. The Natural Gas Gathering and Processing segment offers midstream services to producers in North Dakota, Montana, Wyoming, Kansas and Oklahoma. The Natural Gas Liquids segment owns and operates facilities that gather, fractionate, treat and distribute NGLs and store NGL products, in Oklahoma, Kansas, Texas, New Mexico and the Rocky Mountain region, which includes the Williston, Powder River and DJ Basins, where it provides midstream services to producers of NGLs and deliver those products to the two market centers, one in the Mid-Continent in Conway, Kansas and the other in the Gulf Coast in Mont Belvieu, Texas. The Natural Gas Pipelines segment provides transportation and storage services to end users. The company was founded in 1906 and is headquartered in Tulsa, OK.

Oneok Inc.

ONEOK (OKE) is trending following strong earnings and a dividend increase, reinforcing its position in the growing natural gas and NGL midstream sector, although the stock's short-term price volatility is a key discussion point among investors.

Huntsman Corp. engages in the manufacturing of differentiated organic chemical products. It operates through the following segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment manufactures and markets polyurethane chemicals, including MDI products, PO, polyols, PG, TPU, aniline, and MTBE. The Performance Products segment produces and sells amines, surfactants, LAB, and maleic anhydride to a variety of consumer and industrial end markets. The Advanced Materials segment provides basic liquid and solid epoxy resins, specialty resin compounds, cross linking, matting and curing agents, epoxy, acrylic, and polyurethane based polymer products. The company was founded by Jon Meade Huntsman Sr. in 1970 and is headquartered in The Woodlands, TX.

Huntsman Corp

Huntsman Corp faces strong negative sentiment after cutting its Q4 guidance due to an unexpected facility outage and significantly reducing its dividend. Community discussion highlights ongoing concerns about persistent pricing pressure and weak demand in the cyclical chemicals sector, while some long-term investors are viewing current lows as an attractive accumulation point.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced it will be presenting at...

Short Interest in Forte Biosciences, Inc. (NASDAQ:FBRX) Expands By 55.5%

Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the recipient of a large increase in short interest in January. As of January 15th, there was short interest totaling 795,862 shares, an...

Federated Hermes Inc. Acquires 563,147 Shares of Forte Biosciences, Inc. $FBRX

Federated Hermes Inc. boosted its holdings in Forte Biosciences, Inc. (NASDAQ:FBRX - Free Report) by 52.5% in the third quarter, according to the company in its most recent 13F filing with the SEC...

Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX)

Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the target of unusually large options trading activity on Wednesday. Stock traders purchased 30,205 call options on the stock. This is an...

Stock Traders Buy Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX)

Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 30,205 call options on the stock. This is an increase of...

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on developing FB102, which is a proprietary anti-CD122 monoclonal antibody therapeutic...

Forte Biosciences, Inc. (NASDAQ:FBRX) Given Average Rating of "Moderate Buy" by Brokerages

Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) has earned a consensus rating of "Moderate Buy" from the five research firms that are presently covering the firm, MarketBeat reports. One...

Stock Traders Purchase High Volume of Forte Biosciences Call Options (NASDAQ:FBRX)

Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Traders acquired 30,205 call options on the company. This...

Forte Biosciences Target of Unusually High Options Trading (NASDAQ:FBRX)

Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the recipient of unusually large options trading on Wednesday. Stock investors purchased 30,205 call options on the company. This is an...

Forte Biosciences, Inc. (NASDAQ:FBRX) Receives Average Recommendation of "Moderate Buy" from Brokerages

Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the five research firms that are presently covering the company, Marketbeat.com...

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Current Price	$32.11
Prev Close	$30.78
Open	$30.78
Dividend Yield	0.00%
50-Day Moving Average	$27.56
Beta	0.62
Avg. Volume	226,307.70
PE Ratio	-7.23

52-Week High	$35.62
52-Week Low	$4.90
Market Capitalization	$402.24M
EPS (Annual)	-$12.17
Price to Book	4.78
Revenue Per Employee	$0.00

FBRX
Forte Biosciences Inc

Feed

News

Sentiment

Fundamentals

Info

Latest FBRX News

FBRXForte Biosciences Inc